Wealth Enhancement Advisory Services’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.84M Buy
100,666
+30,507
+43% +$557K ﹤0.01% 1392
2025
Q1
$1.53M Buy
70,159
+36,565
+109% +$800K ﹤0.01% 1376
2024
Q4
$1.07M Buy
33,594
+19,641
+141% +$627K ﹤0.01% 1491
2024
Q3
$402K Buy
+13,953
New +$402K ﹤0.01% 1955